Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

Part of paid clinical trials in San Jose, California.

Sponsor
University of Utah
Study ID
NCT05444582
Phase
PHASE4
Status
Recruiting

Conditions

  • Contraception

Eligibility Criteria

Sex
FEMALE
Age
16 Years - 35 Years
Healthy Volunteers
Not accepted

Interventions

  • Levonorgestrel 52 MG Intrauterine System — DRUG
    Eligible participants must be 16-35 years old, meet clinic eligibility for IUD placement, and having a LNG 52 mg IUD placed for either: Emergency Contraception (had unprotected intercourse in the last 5 days) OR Same-day start - \>7 days since the onset of last menstrual period and have no report of unprotected intercourse in the last 5 days.

Study Details

This is a prospective clinical research study to test the effectiveness of the Levonorgestrel (LNG) 52 mg Intrauterine Device (IUD) for emergency contraception (EC) and same-day start use that will enroll people receiving care at Planned Parenthood affiliates across the U.S. Our prior work demonstrated efficacy (shows that it works in an ideal setting) for the LNG 52 mg IUD for these uses and this study will test effectiveness (how well it works in the real world) in a larger, heterogenous population in a usual care setting where participants select their method and are not randomly assigned to it. The study population will include people initiating an LNG 52 mg IUD and meet inclusion and exclusion criteria at 8 Planned Parenthood affiliates nationwide. Planned Parenthood Federation of America was the first major healthcare organization to change its practice to incorporate the changes we are studying here. As such, all study participants will be offered the opportunity to choose the interventional IUD at the site they visit. The primary outcome is pregnancy status one month after LNG IUD placement by home urine pregnancy test or clinical record review. Participant follow up concludes one month after enrollment. The purpose of this study is to demonstrate reproducibility of earlier findings in a more heterogenous population. As such, IUD placement is not a study procedure but a component of clinical care. The study interventions only involve study participation and provision of data around the use of the levonorgestrel 52 mg IUD for EC or same day start.

Key Dates

Start date
Nov 7, 2022
Status verified
Apr 2026
Primary completion
Mar 31, 2027
Completion
Jul 31, 2027

Study Design

Enrollment
1,404 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: 52 mg LNG IUD Same Day Start or EC
    Week 1: Text daily for seven days. Report occurrences of the following in the last day: presence or absence of bleeding, spotting, pain, sexual intercourse, use of other methods of contraception, IUD expulsion or removal, and report any additional medical care received. Weeks 2 \& 3: Weekly text survey assessing on which days of the previous week participants experienced bleeding and spotting, sexual intercourse, use of other methods of contraception, IUD expulsion or removal, or experienced adverse events. Week 4 Survey: At 28 days, participants will be asked about pregnancy symptoms, concern about pregnancy, and the result of their urine pregnancy test including a prompt to upload a photo of the test.

Primary Outcome Measure

Number of pregnancies reported in participants at one month post insertion of IUD [ Time Frame: One Month ]

Central Contacts

Locations (8)

FacilityCityStateZIPSite coordinators
Planned Parenthood Mar MonteSan JoseCalifornia95126
Corinne Sexsmith
Planned Parenthood of the Rocky MountainsDenverColorado80207
Corinne Sexsmith
Planned Parenthood IllinoiChicagoIllinois60603
Corinne Sexsmith
Planned Parenthood League of MassachusettsBostonMassachusetts02215
Corinne Sexsmith
Planned Parenthood North Central StatesSaint PaulMinnesota55114-
Planned Parenthood Columbia WillamettePortlandOregon97212
Corinne Sexsmith
Planned Parenthood Association of UtahSalt Lake CityUtah84102
Corinne Sexsmith
David Turok, MD
801-581-7647
Planned Parenthood Great Northwest Hawaii, Alaska, Indiana, KentuckySeattleWashington98122
Corinne Sexsmith

Find similar trials in San Jose, CA

Related Studies